OR WAIT null SECS
March 10, 2022
Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.
February 23, 2022
Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.
December 13, 2021
Fareva plans to use blow-fill-seal equipment and ApiJect’s prefilled injector technology to create fill/finish capacity in France.
August 25, 2021
Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.
July 22, 2021
Aenova has announced plans to open a new new can and bottle filling production line in Cornu, Romania.
July 03, 2021
Container and equipment innovations expand applications.
May 25, 2021
The new line can fill prefilled syringes, cartridges, and vials using ready-to-use components.
May 24, 2021
Samsung Biologics plans to support the production of hundreds of millions of doses of Moderna’s vaccine to supply to markets outside of the United States beginning in the third quarter of 2021.
April 06, 2021
Under the terms of the expanded agreement, Catalent will provide Moderna with a new high-speed vial filling line until June 2023 along with inspection, labeling, cartoning, and final packaging for potential pipeline programs.
April 03, 2021
Decontamination, automation, and containment are important considerations for aseptic manufacturing in isolators.